{
  "id": 2102797,
  "title": "Pillar Biosciences partners with LSI Medience for lung cancer screening",
  "url": "https://urgent.news/2026/08/20/pillar-biosciences-partners-with-lsi-medience-for-lung-cancer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-20T08:44:57.000Z",
  "source": {
    "name": "Vietnam Investment Review",
    "slug": "vietnam-investment-review",
    "url": "https://vir.com.vn/pillar-biosciences-partners-with-lsi-medience-for-lung-cancer-screening-159096.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Pillar Biosciences and LSI Medience have partnered for a lung cancer screening project called LC-SCRUM-Asia in Japan. The collaboration aims to screen blood-based samples from 2,000 patients over two years using Pillar's oncoReveal Essential+ assay. This assay has been validated at LSI Medience for detecting circulating cell-free DNA and RNA in lung cancer patients, providing accurate and accessible liquid biopsy solutions for genomic analysis. The project supports precision oncology research and aims to identify genomic alterations relevant to the project's objectives.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}